Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
The Not So Rare Challenge that Faces Rare Disease Development: Demonstrate Value
Track : Track 17: Rare/Orphan Diseases
Program Code: 416
Date: Thursday, June 27, 2013
Time: 9:00 AM to 10:30 AM  EST
Location: 154
CHAIR :
 Charles A. Stevens, JD,MBA (SCHNON), Vice President and General Manager, PAREXEL Consulting, United States
SPEAKER (S):
Igor Gorlach, (SPKNON), Associate, Foley Hoag LLP, United States
Jim Long, (SPKNON), Co-Founder and Principal, BioSolutia, United States
Description
Increased development of orphan products has changed how payer regulators view rare diseases. Rare disorders can now have several products FDA indicated for use; this requires that developers demonstrate the value of these rare disease products.

Session Recording
(Code: 416)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON5 Comp Access: Thursday Online Access Package - June 27, 2013
Handout Online
(Code: 416)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON5 Comp Access: Thursday Online Access Package - June 27, 2013
The Not So Rare Challenge that Faces Rare Disease Development: Demonstrate Value